• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[乳腺癌的四组分化疗与放射治疗]

[4-component chemotherapy and radiation therapy of breast cancer].

作者信息

Gritsaĭ A A, Lichinitser M R, Vyshinskaia G V, Kondrat'eva A P, Aplevich N N

出版信息

Ter Arkh. 1986;58(9):105-8.

PMID:3787480
Abstract

The treatment schedule for disseminated breast carcinoma has been developed. It includes the use of adriamycin (30 mg/m2, days 1, 8, 15), methotrexate (30 mg/m2, day 1), 5-FU (600 mg/m2, day 8), and cyclophosphamide (400 mg/m2, day 15 i. v. by jet injection). A complete response was obtained in 50 to 56% of the patients, with remissions lasting for an appreciable period of time. The use of chemotherapy according to the described schedule combined with radiation of the bones of the pelvis and lumbar part of the spine brought about complete or partial reparation of the osteolytic, osteoblastic and mixed metastatic foci in 76.2% of the patients.

摘要

已制定出播散性乳腺癌的治疗方案。该方案包括使用阿霉素(30毫克/平方米,第1、8、15天)、甲氨蝶呤(30毫克/平方米,第1天)、5-氟尿嘧啶(600毫克/平方米,第8天)和环磷酰胺(400毫克/平方米,第15天,静脉推注)。50%至56%的患者获得了完全缓解,缓解期持续了相当长的时间。按照所述方案使用化疗并结合骨盆和腰椎骨的放疗,使76.2%的患者的溶骨性、成骨性和混合性转移灶实现了完全或部分修复。

相似文献

1
[4-component chemotherapy and radiation therapy of breast cancer].[乳腺癌的四组分化疗与放射治疗]
Ter Arkh. 1986;58(9):105-8.
2
[Adriablastin (doxorubicin) in the combined chemotherapy of patients with disseminated forms of breast cancer].[阿霉素(多柔比星)在播散型乳腺癌患者联合化疗中的应用]
Antibiotiki. 1984 Jun;29(6):463-8.
3
[Use of adriamycin in the treatment of metastatic breast cancer].[阿霉素在转移性乳腺癌治疗中的应用]
Vopr Onkol. 1984;30(6):67-73.
4
Sequential methotrexate and 5-FU in CMFP (cyclophosphamide, methotrexate, 5-FU, and prednisone) therapy for breast cancer.
Cancer Treat Rep. 1984 Jun;68(6):877-9.
5
[Systemic chemotherapy of mammary carcinoma: plasma and tissue concentrations of 5-fluorouracil and adriamycin, and result of CAF and CMF therapy of breast cancer].
Gan To Kagaku Ryoho. 1984 Mar;11(3):415-9.
6
Long term follow-up of women treated with 16-week, dose-intensive adjuvant chemotherapy for high risk breast carcinoma.高危乳腺癌患者接受16周剂量密集辅助化疗后的长期随访
Cancer. 1999 Feb 15;85(4):899-904.
7
Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.吡柔比星联合5-氟尿嘧啶和环磷酰胺治疗转移性乳腺癌的II期临床与药理学研究
Clin Cancer Res. 1995 Jul;1(7):691-7.
8
[Criteria for evaluating the efficacy of treatment of breast cancer metastases to the bones].[评估乳腺癌骨转移治疗疗效的标准]
Med Radiol (Mosk). 1986 Feb;31(2):28-31.
9
Phase I/II study of dose-intense doxorubicin/paclitaxel/cyclophosphamide with peripheral blood progenitor cells and cytokine support in patients with metastatic breast cancer.转移性乳腺癌患者接受剂量密集型阿霉素/紫杉醇/环磷酰胺联合外周血祖细胞及细胞因子支持的I/II期研究。
Semin Oncol. 1997 Oct;24(5 Suppl 17):S17-77-S17-80.
10
Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial.高危乳腺癌患者中传统辅助化疗与单周期、自体移植支持的大剂量晚期强化化疗的随机试验
J Natl Cancer Inst. 2004 Jul 21;96(14):1076-83. doi: 10.1093/jnci/djh188.